Thyrocare Technologies

Thyrocare Technologies stocks: Buy Thyrocare Technologies, target price Rs 725: ICICI Securities

Thyrocare Technologies stocks: Buy Thyrocare Technologies, target price Rs 725: ICICI Securities

April 16, 2024

omicron: The mutated Covid virus will never really go away: A Velumani

omicron: The mutated Covid virus will never really go away: A Velumani

November 29, 2021

PharmEasy buyout puts Thyrocare in a different league

PharmEasy buyout puts Thyrocare in a different league

June 28, 2021

PharmEasy gets $300 million booster shot for Thyrocare deal

PharmEasy gets $300 million booster shot for Thyrocare deal

June 28, 2021

Pharmeasy to acquire 66% stake in diagnostics chain Thyrocare, to make open offer to grab additional 26%

Pharmeasy to acquire 66% stake in diagnostics chain Thyrocare, to make open offer to grab additional 26%

June 25, 2021

PharmEasy to acquire 66% stake in Thyrocare Tech, to make open offer to grab additional 26%

PharmEasy to acquire 66% stake in Thyrocare Tech, to make open offer to grab additional 26%

June 25, 2021

Thyrocare Technologies share price: Reduce Thyrocare Technologies, target price Rs 985: ICICI Securities

Thyrocare Technologies share price: Reduce Thyrocare Technologies, target price Rs 985: ICICI Securities

May 12, 2021

COVID-19 test labs across the country are at their limits, says Thyrocare Tech MD, Dr Velumani

Covid tests: Thyrocare’s Covid-19 labs working at full capacity, can’t do more tests: MD

April 14, 2021

COVID-19 test labs across the country are at their limits, says Thyrocare Tech MD, Dr Velumani

COVID-19 test labs across the country are at their limits, says Thyrocare Tech MD, Dr Velumani

April 14, 2021

Covid testing price capping has affected diagnostic industry: Dr A Velumani, Thyrocare

Covid testing price capping has affected diagnostic industry: Dr A Velumani, Thyrocare

April 6, 2021